-+ 0.00%
-+ 0.00%
-+ 0.00%

Boji Pharmaceutical announced that the information disclosure obligors Wang Tingchun, Zhao Lingli, and Hengqin Guangjin Meimei Fund Management Co., Ltd. - Guangjin Meimei Fermi No. 13 Private Equity Investment Fund reduced their total shareholding ratio from 38.55% to 35.00% due to equity incentive plans, equity distribution, share holdings reduction, and issuance of shares to specific targets.

Zhitongcaijing·12/03/2025 11:41:07
Listen to the news
Boji Pharmaceutical announced that the information disclosure obligors Wang Tingchun, Zhao Lingli, and Hengqin Guangjin Meimei Fund Management Co., Ltd. - Guangjin Meimei Fermi No. 13 Private Equity Investment Fund reduced their total shareholding ratio from 38.55% to 35.00% due to equity incentive plans, equity distribution, share holdings reduction, and issuance of shares to specific targets.